H Enzan Selected Research

H Enzan Research Topics

Disease

17	Neoplasms (Cancer) 01/2006 - 01/2000
7	Carcinoma (Carcinomatosis) 03/2006 - 09/2000
6	Renal Cell Carcinoma (Grawitz Tumor) 06/2005 - 05/2001
4	Fibrosis (Cirrhosis) 01/2008 - 01/2000
3	Adenocarcinoma 03/2006 - 04/2001
2	Carcinoid Tumor (Carcinoid) 01/2005 - 04/2001
2	Hepatocellular Carcinoma (Hepatoma) 07/2004 - 07/2001
2	Oxyphilic Adenoma (Oncocytoma) 12/2001 - 10/2001
2	Breast Neoplasms (Breast Cancer) 11/2000 - 06/2000
1	Stomach Neoplasms (Stomach Cancer) 03/2006
1	Peptic Ulcer (Peptic Ulcers) 01/2006
1	Metaplasia 06/2005
1	Tubal Pregnancy 01/2004
1	Islet Cell Adenoma (Islet Cell Tumors) 01/2004
1	Papillary Carcinoma 12/2002
1	Adenoma (Adenomas) 12/2002
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 10/2002
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2002
1	Medullary Carcinoma 10/2002
1	Angiomyoma (Angioleiomyoma) 05/2002
1	Ductal Carcinoma 01/2002
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 08/2001
1	Thrombosis (Thrombus) 07/2001
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 06/2001
1	Phyllodes Tumor (Cystosarcoma Phylloides) 04/2001
1	Pain (Aches) 04/2001
1	Appendicitis 04/2001
1	Infections 04/2001
1	Colonic Neoplasms (Colon Cancer) 04/2001
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2001
1	Eosinophilia 02/2001
1	Inflammation (Inflammations) 02/2001
1	Alcoholic Fatty Liver 11/2000
1	Fatty Liver 11/2000
1	Kidney Neoplasms (Kidney Cancer) 10/2000
1	Granular Cell Tumor 05/2000
1	Proteinuria 01/2000
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2000
1	Colorectal Neoplasms (Colorectal Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

6	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 01/2006 - 09/2000
4	Keratins (Keratin)IBA 03/2006 - 01/2004
4	Capsules (Microcapsules)IBA 01/2005 - 12/2002
3	Monoclonal AntibodiesIBA 07/2004 - 10/2000
3	beta CateninIBA 01/2002 - 04/2001
2	CAM 5.2 antigenIBA 03/2006 - 01/2006
2	Chromogranin AIBA 01/2006 - 04/2001
2	Carcinoembryonic AntigenIBA 07/2005 - 04/2001
2	Estrogen ReceptorsIBA 07/2005 - 11/2000
2	Messenger RNA (mRNA)IBA 01/2005 - 10/2001
2	Calmodulin-Binding Proteins (Caldesmon)IBA 07/2004 - 12/2002
2	OsteonectinIBA 04/2001 - 05/2000
2	Phosphopyruvate Hydratase (Enolase)IBA 04/2001 - 05/2000
2	VimentinIBA 04/2001 - 05/2000
2	VinculinIBA 04/2001 - 10/2000
2	Tamoxifen FDA LinkGeneric 11/2000 - 06/2000
1	Coloring Agents (Dyes)IBA 01/2008
1	PAceinIBA 01/2008
1	SynaptophysinIBA 01/2006
1	Uroplakin IIIIBA 07/2005
1	monoclonal antibody D2-40IBA 07/2005
1	Apoprotein(a) (Apolipoprotein (a))IBA 07/2005
1	Surface-Active Agents (Surfactants)IBA 07/2005
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2005
1	Thyroid Nuclear Factor 1IBA 07/2005
1	ElementsIBA 06/2005
1	CollagenIBA 01/2005
1	Collagen Type I (Type I Collagen)IBA 01/2005
1	Indicators and Reagents (Reagents)IBA 01/2004
1	IronIBA 01/2003
1	Mitochondrial DNA (mtDNA)IBA 01/2003
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 10/2002
1	Interferon-gamma (Interferon, gamma)IBA 10/2002
1	PaxillinIBA 12/2001
1	Tetraspanin 29IBA 10/2001
1	Proteins (Proteins, Gene)FDA Link 10/2001
1	Bleomycin (Blenoxane)FDA LinkGeneric 08/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2001
1	PeplomycinIBA 08/2001
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 07/2001
1	Thymidine PhosphorylaseIBA 07/2001
1	Arginine (L-Arginine)FDA Link 06/2001
1	DNA (Deoxyribonucleic Acid)IBA 04/2001
1	Cadherins (E-Cadherin)IBA 04/2001
1	Serotonin (5 Hydroxytryptamine)IBA 04/2001
1	Keratin-20 (Cytokeratin 20)IBA 04/2001
1	LipopolysaccharidesIBA 02/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2001
1	Interleukin-5 (Interleukin 5)IBA 02/2001
1	Estrogens (Estrogen)FDA Link 06/2000
1	OsteopontinIBA 05/2000
1	ReninIBA 03/2000
1	IsoenzymesIBA 01/2000
1	Polypeptide N-acetylgalactosaminyltransferaseIBA 01/2000
1	MucinsIBA 01/2000
1	EnzymesIBA 01/2000
1	Uridine Diphosphate (UDP)IBA 01/2000

Therapy/Procedure

1	Gastrectomy 03/2006
1	Appendectomy 04/2001
1	Therapeutics 04/2001
1	Ligation 01/2000